Third, although we identified that FCGR3A expression was associated with survival in some tumor patients and affected immune cell infiltration, we were unable to prove a clear causal relationship between FCGR3A altering immune infiltration and affecting patient survival. The gene discussed is FCGR3A; the disease is neoplasm.